Prescription drug · NDA
Yutiq (Fluocinolone acetonide) NDC 68611-180
Fluocinolone acetonide .18 mg/1 · Implant · Intravitreal · ANI Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68611-180-01 | 6861101800168611018001 | 1 POUCH in 1 CARTON (68611-180-01) / 1 APPLICATOR in 1 POUCH / 1 IMPLANT in 1 APPLICATORMarketed from May 17, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Yutiq
- Generic name (nonproprietary)
- fluocinolone acetonide
- Active ingredients
- Fluocinolone acetonide — .18 mg/1
- Dosage form
- Implant
- Route
- Intravitreal
- Labeler
- ANI Pharmaceuticals, Inc.NDC labeler code 68611
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 210331
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 68611-180_f684c980-0cfe-11f1-b4ac-0800200c9a66SPL ID f684c980-0cfe-11f1-b4ac-0800200c9a66SPL set ID f270cad8-ed82-4969-b785-831a1910bfa6RxCUI 2099361, 2099366UNII 0CD5FD6S2MUPC 0368611180017
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N468611018001followed by a unit qualifier and the quantityPackage 68611-0180-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. INDICATIONS AND USAGE YUTIQ ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. YUTIQ contains a corticosteroid and is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68611-180
- What is NDC 68611-180?
- 68611-180 is the product NDC for Yutiq (fluocinolone acetonide), Fluocinolone acetonide .18 mg/1 implant, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Yutiq (Fluocinolone acetonide).
- What is the active ingredient?
- Fluocinolone acetonide.
- Who is the labeler?
- ANI Pharmaceuticals, Inc., NDC labeler code 68611. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Yutiq?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.